[ad_1]
FDA Joint Advisory Committee Votes in Favor of Perrigo’s Opill® Daily Oral Contraceptive for OTC Use
DUBLIN, May 10, 2023 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that…
[ad_2]
Source link